Accumulation going on still. This is the last level prior to 12. If you haven't bought yet do so while the risk/reward is still very favorable. At 12 it gets more speculative at least in the ST. I don't expect 12 to be too formidable.
GERN's pullback today is healthy considering yesterday's gains. Shorts don't have a clue w/respect to this one. How do you value a company that could cure cancer, spinal cord injuries, Parkinsons (even partially)? May not happen, but hey makes for a great story doesn't it? Still believe it's very undervalued here assuming just partial success of any one of their treatments.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.